Research Topics
Species | Christopher Alexander FrenchSummaryAffiliation: Massachusetts General Hospital Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
The importance of diagnosing NUT midline carcinomaChristopher A French
Department of Pathology, Brigham and Women s Hospital, Harvard Medical School, 75 Francis St, Boston, MA 02115, USA
Head Neck Pathol 7:11-6. 2013..The emergence of these promising targeted therapies gives hope that NMC may one day be effectively treated and provides a strong rationale for diagnostic testing for NMC...
Pathogenesis of NUT midline carcinomaChristopher A French
Department of Pathology, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
Annu Rev Pathol 7:247-65. 2012..These insights provide a rationale for targeted therapy of NMC, which is almost uniformly refractory to conventional chemotherapy and radiotherapy...
NUT midline carcinomaChristopher Alexander French
Department of Pathology, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
Cancer Genet Cytogenet 203:16-20. 2010..There still is no effective treatment for NMC, there are no guidelines, and current approaches to treatment are based on discussions among a few oncologists who each have had a single experience treating this disease...
Demystified molecular pathology of NUT midline carcinomasChristopher A French
Department of Pathology, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
J Clin Pathol 63:492-6. 2010..NMC is diagnosed by detection of NUT rearrangement by fluorescence in situ hybridisation or reverse transcriptase PCR. Due its rarity and lack of characteristic histological features, most cases of NMC currently go unrecognised...
BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinomaChristopher A French
Department of Pathology, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
Cancer Res 63:304-7. 2003..Very few fusion oncogenes have been identified in epithelial tumors, and BRD4-NUT is the first fusion oncogene mechanism identified in a highly lethal form of carcinoma...
Midline carcinoma of children and young adults with NUT rearrangementChristopher A French
Department of Pathology, Brigham and Women s Hospital, 75 Francis St, Boston, MA 02115, USA
J Clin Oncol 22:4135-9. 2004..We sought to amass a more definitive series of tumors with NUT and/or BRD4 gene rearrangements and to determine distinct clinicopathologic features...
Carcinomas of the upper aerodigestive tract with rearrangement of the nuclear protein of the testis (NUT) gene (NUT midline carcinomas)Edward B Stelow
Department of Pathology, University of Virginia, Jefferson Park Avenue, Charlottesville, VA 22908, USA
Adv Anat Pathol 16:92-6. 2009..Our current understanding of the molecular pathogenesis of the disease is also discussed, along with the differential diagnosis for undifferentiated or poorly differentiated malignancy of the upper aerodigestive tract...
NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tractEdward B Stelow
Department of Pathology, University of Virginia, Charlottesville, VA, USA
Am J Surg Pathol 32:828-34. 2008..The histologic features of these tumors are described in detail...
BRD4-NUT carcinoma of the mediastinum in a pediatric patient: multidetector computed tomography imaging findingsBenjamin A Nelson
Department of Pediatrics, Pulmonary Division, Massachusetts General Hospital, Boston, MA, USA
J Thorac Imaging 25:W93-6. 2010....
Molecular detection of PPAR gamma rearrangements and thyroid carcinoma in preoperative fine-needle aspiration biopsiesChristopher A French
Department of Pathology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
Endocr Pathol 19:166-74. 2008..The application of specific mutations to preoperative diagnosis of thyroid carcinoma is predicted to improve the accuracy and reduce the costs of treating patients with thyroid tumors...
Applications of fluorescence in situ hybridization in cytopathology: a reviewAndre M Oliveira
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
Acta Cytol 49:587-94. 2005..Furthermore, due to its feasibility for virtually all types of cytologic specimens, a new and exciting era in both investigative and clinical cytopathology is expected...
The cytologic features of NUT midline carcinomaAndrew M Bellizzi
Department of Pathology, The Ohio State University Medical Center, Columbus, Ohio, USA
Cancer 117:508-15. 2009..Although the tumor was originally noted in young persons, we have subsequently identified 5 adult cases. To our knowledge, the cytology of NMC has not been systematically described...
The role of chromosomal translocation (15;19) in the carcinoma of the upper aerodigestive tract in childrenReza Rahbar
Department of Otolaryngology, Children s Hospital, Boston, MA 02115, USA
Otolaryngol Head Neck Surg 129:698-704. 2003..To further evaluate the role of chromosomal translocation (15;19) in the presentation of the carcinoma (CA) of the upper aerodigestive tract...
Genetic and biological subgroups of low-stage follicular thyroid cancerChristopher A French
Division of Endocrinology, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA
Am J Pathol 162:1053-60. 2003..The findings support a model in which separate genetic alterations initiate distinct pathways of oncogenesis in thyroid carcinoma subtypes...
Successful treatment of a child with t(15;19)-positive tumorFredrik Mertens
Department of Clinical Genetics, Lund University Hospital, Lund, Sweden
Pediatr Blood Cancer 49:1015-7. 2007..More importantly, our results also demonstrate that at least some patients with t(15;19)-positive tumors may be successfully treated...
Research Grants
- T(15;19) in Aggressive Pediatric CarcinomaChristopher French; Fiscal Year: 2006..These studies will also reveal the range of primary sites from which t(15;19)+ carcinomas arise. ..
- Pathogenesis of NUT-Rearranged CarcinomaChristopher A French; Fiscal Year: 2010..3. To identify the transcriptional targets of BRD4-NUT1 that are responsible for the blockade of differentiation in BRD4-NUT1 carcinoma cells. ..
- Pathogenesis of NUT-Rearranged CarcinomaChristopher A French; Fiscal Year: 2010..3. To identify the transcriptional targets of BRD4-NUT1 that are responsible for the blockade of differentiation in BRD4-NUT1 carcinoma cells. ..
